|
1
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kao PN, Chen L, Brock G, Ng J, Kenny J,
Smith AJ and Corthésy B: Cloning and expression of cyclosporin A-
and FK506-sensitive nuclear factor of activated T-cells: NF45 and
NF90. J Biol Chem. 269:20691–20699. 1994.PubMed/NCBI
|
|
3
|
Reichman TW, Muñiz LC and Mathews MB: The
RNA binding protein nuclear factor 90 functions as both a positive
and negative regulator of gene expression in mammalian cells. Mol
Cell Biol. 22:343–356. 2002. View Article : Google Scholar
|
|
4
|
Zhao G, Shi L, Qiu D, Hu H and Kao PN:
NF45/ILF2 tissue expression, promoter analysis, and interleukin-2
transactivating function. Exp Cell Res. 305:312–323. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ni S, Zhu J, Zhang J, Zhang S, Li M, Ni R,
Liu J, Qiu H, Chen W, Wang H, et al: Expression and clinical role
of NF45 as a novel cell cycle protein in esophageal squamous cell
carcinoma (ESCC). Tumour Biol. 36:747–756. 2015. View Article : Google Scholar
|
|
6
|
Shamanna RA, Hoque M, Pe'ery T and Mathews
MB: Induction of p53, p21 and apoptosis by silencing the NF90/NF45
complex in human papilloma virus-transformed cervical carcinoma
cells. Oncogene. 32:5176–5185. 2013. View Article : Google Scholar
|
|
7
|
Huang Q, He X, Qiu X, Liu X, Sun G, Guo J,
Ding Z, Yang L, Ban N, Tao T, et al: Expression of NF45 correlates
with malignant grade in gliomas and plays a pivotal role in tumor
growth. Tumour Biol. 35:10149–10157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wan C, Gong C, Ji L, Liu X, Wang Y, Wang
L, Shao M, Yang L, Fan S, Xiao Y, et al: NF45 overexpression is
associated with poor prognosis and enhanced cell proliferation of
pancreatic ductal adenocarcinoma. Mol Cell Biochem. 410:25–35.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim VN: Small RNAs: Classification,
biogenesis, and function. Mol Cells. 19:1–15. 2005.PubMed/NCBI
|
|
11
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Subramanian S, Lui WO, Lee CH, Espinosa I,
Nielsen TO, Heinrich MC, Corless CL, Fire AZ and van de Rijn M:
MicroRNA expression signature of human sarcomas. Oncogene.
27:2015–2026. 2008. View Article : Google Scholar
|
|
14
|
Sarver AL, Phalak R, Thayanithy V and
Subramanian S: S-MED: Sarcoma microRNA expression database. Lab
Invest. 90:753–761. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Calin GA, Cimmino A, Fabbri M, Ferracin M,
Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI,
et al: MiR-15a and miR-16-1 cluster functions in human leukemia.
Proc Natl Acad Sci USA. 105:5166–5171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rossi JJ: New hope for a microRNA therapy
for liver cancer. Cell. 137:990–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kota J, Chivukula RR, O'Donnell KA,
Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P,
Torbenson M, Clark KR, et al: Therapeutic microRNA delivery
suppresses tumorigenesis in a murine liver cancer model. Cell.
137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang L, Chen F, Pang EJ, Zhang ZQ, Jin BW
and Dong WF: MicroRNA-182 inhibits proliferation through targeting
oncogenic ANUBL1 in gastric cancer. Oncol Rep. 33:1707–1716.
2015.PubMed/NCBI
|
|
20
|
Dai X, Ge J, Wang X, Qian X, Zhang C and
Li X: OCT4 regulates epithelial-mesenchymal transition and its
knockdown inhibits colorectal cancer cell migration and invasion.
Oncol Rep. 29:155–160. 2013.
|
|
21
|
Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng
GQ, Wan XX, He QY, Li JH, Qu JQ, et al: Activation of EGFR promotes
squamous carcinoma SCC10A cell migration and invasion via inducing
EMT-like phenotype change and MMP-9-mediated degradation of
E-cadherin. J Cell Biochem. 112:2508–2517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung H, Lee KP, Park SJ, Park JH, Jang YS,
Choi SY, Jung JG, Jo K, Park DY, Yoon JH, et al: TMPRSS4 promotes
invasion, migration and metastasis of human tumor cells by
facilitating an epithelial-mesenchymal transition. Oncogene.
27:2635–2647. 2008. View Article : Google Scholar
|
|
23
|
Maier HJ, Schmidt-Strassburger U, Huber
MA, Wiedemann EM, Beug H and Wirth T: NF-kappaB promotes
epithelial-mesenchymal transition, migration and invasion of
pancreatic carcinoma cells. Cancer Lett. 295:214–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen D, Huang J, Zhang K, Pan B, Chen J,
De W, Wang R and Chen L: MicroRNA-451 induces
epithelial-mesenchymal transition in docetaxel-resistant lung
adenocarcinoma cells by targeting proto-oncogene c-Myc. Eur J
Cancer. 50:3050–3067. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi
Y, Wu X, Cheng L, Ma C, Xia J, et al: Curcumin inhibits cell growth
and invasion through upregulation of miR-7 in pancreatic cancer
cells. Toxicol Lett. 231:82–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Costello E, Greenhalf W and Neoptolemos
JP: New biomarkers and targets in pancreatic cancer and their
application to treatment. Nat Rev Gastroenterol Hepatol. 9:435–444.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kern SE, Shi C and Hruban RH: The
complexity of pancreatic ductal cancers and multidimensional
strategies for therapeutic targeting. J Pathol. 223:295–306. 2011.
View Article : Google Scholar
|
|
32
|
Chang CJ, Chao CH, Xia W, Yang JY, Xiong
Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, et al: p53 regulates
epithelial-mesenchymal transition and stem cell properties through
modulating miRNAs. Nat Cell Biol. 13:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bracken CP, Gregory PA, Kolesnikoff N,
Bert AG, Wang J, Shannon MF and Goodall GJ: A double-negative
feedback loop between ZEB1-SIP1 and the microRNA-200 family
regulates epithelial-mesenchymal transition. Cancer Res.
68:7846–7854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gregory PA, Bracken CP, Bert AG and
Goodall GJ: MicroRNAs as regulators of epithelial-mesenchymal
transition. Cell Cycle. 7:3112–3118. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sankpal UT, Nagaraju GP, Gottipolu SR,
Hurtado M, Jordan CG, Simecka JW, Shoji M, El-Rayes B and Basha R:
Combination of tolfenamic acid and curcumin induces colon cancer
cell growth inhibition through modulating specific transcription
factors and reactive oxygen species. Oncotarget. 7:3186–3200.
2015.PubMed/NCBI
|
